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De novo stress urinary incontinence (SUI) may occur in up to 80% of clinically continent women following 
genitourinary prolapse surgery. This had resulted in an increase in the rate of concurrent continence surgery during 
prolapse repair from 38% in 2001 to 47% in 2009 in the United States. To date, there is no local data available to 
estimate the prevalence of occult SUI (OSUI) among Malaysian women awaiting surgery. Therefore, this study was 
conducted to elicit the prevalence of occult SUI and its associated risks factors in patients awaiting prolapse surgery.  
We retrospectively studied the records of 296 consecutive women with significant pelvic organ prolapse awaiting 
reconstructive repair. All patients attended the Urogynaecology Unit in Hospital Kuala Lumpur Malaysia between 
October 2007 and September 2011. They had undergone standardized interviews, clinical examinations and 
urodynamic studies. During the urodynamic testings, all prolapses were reduced using ring pessaries to elicit OSUI. 
Primary outcome was the prevalence of OSUI with prolapse reduction to predict possibility of developing de novo 
SUI following prolapse surgery. Secondary outcome was the assessment of potential risk factors for OSUI. Among 
the 296 women studied, 121 (40.9%) were found to have OSUI. The risk factors associated with OSUI included age, 
BMI, numbers of SVD, recurrent UTI, reduction of urinary flow symptoms and grade 2 to 4 central compartment 
prolapses. We concluded that preoperative urodynamic testing with reduction of prolapse is useful to identify women 
with OSUI. This is important for preoperative counselling as well as planning for one step approach of prophylactic 
concomitant anti-incontinence procedures during prolapse surgery in order to avoid postoperative de novo SUI. 
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Female pelvic organ prolapse is a major health issue 
affecting women’s quality of life. It is estimated that up 
to 50% of women worldwide have some degree of 
genitourinary prolapse (1). The likelihood of prolapse 
surgery in their lifetime is reported to be greater than 
10% by the age of 80 (2). In addition, the rate of 
concurrent prolapse repair and continence procedures 
appears to be increasing. Data from the United States 
National Inpatient study revealed an increment in the 
percentage of concurrent continence surgery for apical 
prolapse repair procedures, from 38% in 2001 to 47% in 
2009 (3). This could be attributed to the increase in the 
incidence of de novo postoperative stress urinary 
incontinence (SUI). 
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De novo SUI after prolapse corrective surgery is 
affecting 36% to 80% of clinically continent women 
with advanced prolapse (4). OSUI is elicited when a 
continent woman has a positive cough test on prolapse 
reduction during urodynamic study (5). Urodynamic 
diagnostic criteria include leakage with straining in the 
absence of detrusor contraction or a decreased in 
maximal urethral closure with prolapse reduction (4). 
The mechanism by which severe prolapse particularly 
large cystocele may mask SUI in an apparently 
continent women is via the cushioning effect of the 
cystocele which dissipated the effect of the abdominal 
pressure on the bladder outlet. In addition, the prolapsed 
bladder on the urethra may also cause urethral kinking 
causing an increase in the intra-urethral pressure (6). As 
for posterior wall defect, the prolapsed bowel may 
compress and/or support the bladder neck, providing 
continence during straining. Corrective prolapse surgery 
may reverse this mechanism, rendering these women to 
develop postoperative SUI. In contrast, overcorrection 
may lead to voiding dysfunction (7). Therefore, 
preoperative detection of OSUI may justify the 
indication for concomitant prophylactic anti-
incontinence procedure during prolapse surgery in 
women at risk (1). 
 
History of preoperative SUI is identified as the sole 
independent predictor of subjective (RR 4.03) and 
objective SUI (RR 4.67; 95%CI) and subsequent anti-
incontinence surgery (RR 6.17) after laparoscopic 
prolapse surgery (sacrocolpopexy) in patient with 
negative occult stress testing (8). In another study by the 
Belgium group, it was found that no statistical 
association existed between clinical data prior to 
operation (age, body mass index, maximum urethral 
closure pressure, medical history of urge urinary 
incontinence (UUI) and prolapse surgery, bladder neck 
hypermobility) and de novo SUI after surgery (9). 
 
Currently, there are no local data in Malaysia to 
estimate the prevalence and predict the risks factors of 
OSUI among Malaysian women with pelvic organ 
prolapse. Thus, the aim of this study is of two fold, to 
detect the prevalence of OSUI in Malaysia using a 
larger sample size than previous studies and to 
determine the risk factors of OSUI. 
 
Materials and Methods 
 
This was a retrospective, cross-sectional study spanning 
a period of 4 years from October 2007 to September 
2011, of 296 women with significant pelvic organ 
prolapse awaiting vaginal reconstruction surgery. The 
records of the women who attended the outpatient in 
Urogynaecology clinic of Department of Obstetrics and 
Gynaecology, Kuala Lumpur Hospital were reviewed. 
The subjects were asymptomatic of SUI, but had 
bothersome prolapse symptoms that were staged 
according to Pelvic Organ Prolapse Quantification 
System of the International Continence Society (ICS 
POP-Q). The study was approved by the Institutional 
Review Board of Hospital Kuala Lumpur. The women 
were excluded if they presented with preoperative 
urinary incontinence, concurrent pelvic disease 
requiring laparotomy, previous pelvic surgery and/or 
history of anti-incontinence procedure.  
 
The participants underwent a routine preoperative 
assessment that includes a standardized interview, 
clinical examination, free flowmetry and multichannel 
urodynamic testing. All women had reduction of 
prolapse using a well-fitting ring pessary, making sure 
that there was no urethral compression. Multichannel 
urodynamic were done according to the 
recommendations of the International Continence 
Society.  
 
The observation of SUI during urodynamics 
(urodynamic SUI) is defined as the finding of 
involuntary leakage during filling cystometry associated 
with increased intra-abdominal pressure in the absence 
of a detrusor contraction.  The symptom of SUI is the 
complaint of involuntary loss of urine on effort or 
physical exertion (e.g., sporting activities) or on 
sneezing or coughing.  This is to be differentiated from 
the sign of SUI, which is the observation of involuntary 
leakage from the urethra synchronous with effort or 
physical exertion or on sneezing or coughing. 
 
Urodynamic SUI was defined as unintentional leakage 
of urine upon valsalva manoeuver in the absence of 
simultaneous detrusor contraction, observed in patients 
without prolapse reduction during urodynamic testing. 
These patients were excluded in this study. On the other 
hand, urodynamic OSUI was defined as uncontrolled 
escape of urine diagnosed during a rise in the abdominal 
pressure, without modification in the detrusor pressure 
following prolapse reduction. The findings of 
urodynamic tests in this study were divided into two:  
 
1. negative/normal if no urine leakage observed with 
prolapse reduction  
2. Positive/urodynamic OSUI with presence of 
leakage on prolapse reduction. 
 
The main outcome measures were the prevalence of 
OSUI and its associated risks factors. The data were 
analysed statistically using the simple and multiple 
logistic regression for individual variables and multiple 
variables respectively. Analysis was done using SPSS 
programs with p < 0.05 considered as statistically 
significant. The study was approved by the Clinical 
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A total of 296 patients were recruited into this study. In 
general, voiding function was improved after prolapse 
reduction with a ring pessary. Of the 296 continent 
women, 121 (40.9%) had demonstrable urodynamic 
OSUI with prolapse reduction; the remaining 175 
women (59.1%) had negative findings (Table 1). The 
mean age of the women studied was 58.60 ± 8.7 years 
and the median parity was 3 (Table 2). Majority of them 
were Malay (n=162; 54.7%), followed by Indian (n=75; 
25.3%) and Chinese (n=55; 18.6%). The mean BMI of 
the participants was 26.18kg/m2 (range 20 to 34.9).Two 
hundred and twenty-four (75.7%) were postmenopausal 
and 72 (24.3%) were either pre or perimenopausal; 43 
(19.2%) of the postmenopausal women were on HRT 
(Table 2). According to the International Continence 
Society Pelvic Organ Prolapse Quantification System, 
significant prolapse was defined as prolapse occurring 
at stage 2 or greater. Most of our patients had a mixture 
of 2 or 3 compartments prolapse. Of the 296 women, 
269 (90.9%) and 250 (84.6%) had significant cystocele 
and rectocele respectively. Two hundred and sixty-two 
(88.5%) were diagnosed with significant central 
compartment prolapse. For each significant 
compartment prolapse (stage 2 to 4), majority of them 
had stage 2 prolapse with 109 patients each had 
cystocele and utero-vaginal prolapse and 160 patients 
with rectocele.  
 
A preoperative finding of OSUI is generally accepted as 
a marker for increased likelihood of postoperative SUI 
after prolapse repair. Using multiple logistic regression, 
our study showed significant association between age, 
body mass index, parity, number of vaginal delivery, 
history of recurrent urinary tract infections and reduced 
preoperative urinary flow with the development of 
OSUI (Table 3). In contrast with advanced anterior and 
posterior compartment prolapse, significant (stage 2 -4) 
central compartment prolapse was identified as a risk 
factor for OSUI. More than 80% of women who were 
diagnosed with OSUI in our study had at least grade 2 
or more of pelvic organ prolapse. Variables such as 
parity, menopausal status and history of dysuria were 
not significantly associated with OSUI after controlling 
for the confounders. No association was found between 
ethnicity, smoking status, history of instrumental 
delivery, chronic medical illness and OSUI in this 
study. 
 
Table 1: Preoperative Urodynamic Occult Stress Urinary 
Incontinence Result 
 
Test result No of patients (%) 
Positive 121 (40.9%) 
Negative 175 (59.1%) 
Total 296 (100%) 
 
Table 2: Characteristics of women participated in this study (n = 296) 
 
Variable   Mean (SD) 
Age, mean ± SD (yr)      58.60 ± 8.7 
Body Mass Index (kg/m2)   26.18 ± 4.16 
Parity (median)   3 
Ethnicity    
    Malay   154 (52) 
    Indian   94 (31.8) 
    Chinese   44 (14.9) 
    Others   4 (1.4) 
Marital status    
    Married   237 (80.1) 
    Unmarried/ Widower/Divorced       59 (19.9) 
Menopausal status    
   Postmenopausal   224 (75.7) 
    HRT   43 (19.2) 
    No HRT   181 (80.8) 
    Pre/perimenopausal   72 (24.3) 
Stage of Prolapse Presentation Cystocele Rectocele UV prolapse 
Stage 0 3 (1.0) 4 (1.4) 10 (3.4) 
Stage I 24 (8.1) 42 (14.2) 24 (8.1) 
Stage II 109 (36.8) 160 (54.1) 109 (36.8) 
Stage III 83 (28.0) 28 (9.5) 60 (20.2) 
Stage IV 77 (26.0) 62 (20.9) 93 (31.4) 
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Table 3: Table showing association of different variables with occult SUI 
 
Variable Crude Hazard Ratio (95% CI) P value 
Age 1.044 (1.001 – 1.090) <0.046* 
BMI 1.151 (1.078 – 1.228) <0.001* 
Ethnicity - 0.999 
Menopausal status 1.901 (0.714-5.060) 0.199 
HRT user 0.844 (0.418-1.700) 0.634 
Smoking status 0.737 (0.351-1.549) 0.421 
Parity 1.214(1.086 – 1.352) <0.001* 
History of Mode of Delivery   
      SVD 1.216 (1.086-1.361) <0.001* 
      Forceps 0.845 (0.366-1.949) 0.693 
      Vacuum 0.618 (0.280-1.366) 0.234 
      LSCS 0.737 (0.351-1.549) 0.421 
Medical condition   
      Diabetes mellitus 0.933 (0.559-1.555) 0.790 
      Hypertension 0.693 (0.412-1.165) 0.167 
      Stroke 0.377 (0.033-4.324) 0.433 
      Recurrent UTI 2.578 (1.208-5.498) 0.014* 
Urinary symptoms   
      Frequency 0.290 (0.150-5.536) 0.411 
      Nocturia 0.479 (0.043-5.332) 0.549 
      Reduced flow 0.217 (0.100-0.471) <0.001* 
      Dysuria 9.078 (1.079-76.397) 0.420 
Stage of Prolapse    
      Cystocele   
           Stage I                                      0.000 0.999 
           Stage II 0.000 0.999 
           Stage III 0.531(0.146-1.938) 0.338 
           Stage IV 1.443(0.438-4.756) 0.547 
      Rectocele   
           Stage I 14.019(0.419-46.94) 0.141 
           Stage II 0.179(0.029-1.089) 0.062 
           Stage III 0.290(0.084-1.003) 0.051 
           Stage IV 0.315(0.071-1.396) 0.127 
      UV Prolapse   
           Stage I 0.000 0.999 
           Stage II 0.320(0.02-0.484) 0.013* 
           Stage III 0.101(0.031-0.328) <0.001* 
           Stage IV 1.025(0.354-2.970) 0.03* 
 
Abbreviations: SUI, stress urinary incontinence; BMI, body mass index; HRT, hormone replacement therapy; SVD, spontaneous 
vertex delivery; LSCS, lower segment caesarean section; UV, uterovaginal. Based on multiple logistic regression, asterisk 
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Occult stress urinary incontinence (OSUI) is the 
presence of involuntary urinary leakage on effort or 
exertion which is observed following reduction of co-
existing prolapse. It has been called “masked”, 
“potential”, “latent”, hidden” or “reduced” stress 
urinary incontinence in the literature, prior to the 
standardization of the female pelvic floor dysfunction 
(10). The true incidence of occult stress urinary 
incontinence is not clear and results varied considerably 
between studies. This may be due to lack of 
standardized test and different methods used to 
diagnose occult stress urinary incontinence. A wide 
range of incidence was reported from 6% to 80% (11) 
with clinical diagnosis and about 27% with cystometry 
(12). Others used pressure transmission ratio as an 
indicator for OSUI, with incidences ranging from 36 to 
73% (13). 
 
The need for preoperative screening for OSUI cannot be 
overstated. A Cochrane meta-analysis had shown that 
omitting continence surgery during prolapse repair in 
women with OSUI increased the risk of postoperative 
SUI by 2.2 (CI 1.4 to 3.3) (14). In addition, prophylactic 
anti incontinence procedure was both effective and safe 
in patients with OSUI undergoing prolapse repair (15). 
However, it was associated with de novo detrusor over 
activity (7.6%), urinary tract infections (7.6%) and 
urinary retention (3.8%) (16). Despite fear of morbidity, 
adding prophylactic continence surgery may be justified 
as it is a one-step approach to solve two problems. 
Furthermore, continence surgery at the time of prolapse 
operation had shown to prevent 25% of the women 
from developing postoperative SUI (14). 
 
Previous studies had published prevalence of OSUI 
ranging from 22-87%. This is in agreement with our 
study which showed prevalence of 40.9% (n = 121). In 
contrast, Reena et al. (17) and Rosenzweig et al. (18) 
found higher prevalence of OSUI of 67.9% and 59% 
respectively. This may be attributed to more patients 
with advanced prolapse (stage 3 and above) were 
recruited in their studies compared to our study (mainly 
stage 2 and above). Nevertheless, more than 80% of our 
subjects diagnosed with OSUI had advanced pelvic 
organ prolapse (stage 3 and 4) in all 3 compartments, 
highest occurrence was found in patients with stage 4 
cystocele. These results were supported by several 
studies which found mainly severe degree of pelvic 
organ prolapse masked SUI in clinically continent 
women and those women were at higher risk of 
developing postoperative SUI (5, 14,15,16).  
 
Our prevalence rates of OSUI was higher compared to 
those found in CARE trial (40.9% vs. 19%) (6). This 
could be explained by the difference in repositioning 
method used. Despite various methods of prolapse 
reduction used in the CARE trial, the detection rate of 
OSUI was lower compared to our study which only use 
ring pessary as the reduction method (6). Other authors 
used rectal swabs, Gel horn pessary or Grave’s 
speculum for prolapse reduction (17). Prolapse 
repositioning with rectal swabs was superior in 
detecting OSUI as it significantly lowered the 
midurethral closure pressure and causes a shorter 
functional urethral length compared to other techniques. 
This is because low MUCP and functional urethral 
length during preoperative urodynamic evaluation are 
significant predictors for occult SUI (19). In contrast, 
another consensus showed detection rate was lower 
with pessary than with speculum prolapse reduction 
(20). 
 
Although pessaries are commonly used for prolapse 
reduction and predictive of postoperative stress urinary 
incontinence (4), combination of repositioning tests 
(manual, pessary in the office, or pessary continuous 
use, or combination of two or all) are thought to be 
more predictive in diagnosing occult stress urinary 
incontinence than using a single test alone (4). 
Unfortunately as ring pessary is the only method used in 
our study, we were not able to compare the use of 
various reduction methods. Nevertheless, our detection 
rate is almost similar with Reena et al. whose used ring 
pessary reduction technique with prevalence rate of 
59% (17). Ambulatory pessary test conducted over 
several days is another alternative technique to clinical 
examination as it allows an optimal continence 
screening during the patient’s normal daily life. 
However, there are limitations to this test namely 
unwillingness of some women or failure of pessary 
fitting for several reasons (1). 
 
A study by Chiarelli et al. reported that the prevalence 
rate of stress urinary incontinence among elderly 
Australian females aged 70-75 years was 35% (21). In 
another study conducted in Norway (EPICONT Study) 
which involved over 20,000 women, the rate of 
incontinence in women aged 50 was 30% and steadily 
increased until age of 70 (22). Similarly, older women 
are at higher risk of developing OSUI (17). This is in 
accordance with our findings which suggested a 
significant association between age and OSUI (Crude 
Hazard Ratio 1.044 (1.001 – 1.090), p<0.046). Occult 
SUI was diagnosed in 11 patients (3.7%) below the age 
of 50, in our study.  Women aged 50 years or older had 
twice the risk of OSUI compared to those younger than 
50 years (P<0.005). This is comparable to Lo et al. who 
found that women older than 66 years were 2.86 times 
at greater risk of developing de novo SUI 
postoperatively (19). In addition, age is an important 
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confounding factor in relation to concomitant medical 
illnesses which may aggravate urinary incontinence. 
 
We found a significant correlation between body mass 
index (BMI) and OSUI (Crude Hazard Ratio 1.151 
(1.078 - 1.228), p<0.001). The prevalence of OSUI was 
higher among the obese (BMI >35kg/m2) compared to 
the overweight group (BMI >30 kg/m2), with the 
former 74% versus the latter 48% (p<0.05). The most 
probable explanation for this is an increase in BMI 
resulted in an increase in intra-abdominal and intra-
vesicular pressure. This will increase the risks of 
urethral kinking and subsequently favours the 
development of OSUI. Reversing this effect by weight 
loss would significantly improve incontinence in obese 
women (23). Our data showed similar result with only 
24% of female subject with normal BMI had OSUI.  
 
Previous literature was inconsistent in describing the 
role of menopause and estrogen deficiency in urinary 
incontinence. Reena et al. found postmenopausal 
women had a statistically significant risk of developing 
OSUI (17). This is supported by Lo et al. who showed 
postmenopausal status is independent predictors for de 
novo SUI following extensive POP repair (19). In 
addition, estrogen replacement is thought to alleviate 
incontinence by facilitating proliferation and maturation 
of urethral mucosa in postmenopausal women (24). Our 
study also found the risk of OSUI was increased in 
postmenopausal women and decreased with hormone 
replacement therapy. However, these associations were 
insignificant (Table 3). 
 
Our study demonstrated an increased risk of OSUI 
among women who had vaginal delivery compared to 
other mode of deliveries (p<0.001). A further increase 
was observed among multiparous women with parity ≥ 
7 (p<0.001). These results may suggest that repetitive 
mechanical strain during labour may add to the risk of 
SUI compared to pregnancy alone. This was supported 
by Rortveit et al. (25) who studied over 15,000 women 
and found an association between stress urinary 
incontinence and caesarean delivery compared to 
nulliparous women and more prevalent after a vaginal 
delivery compared to caesarean delivery (EPICONT 
study) (22). In addition, Dietz found an association 
between intra-partum event and development of urinary 
incontinence in later life (26). 
 
We elicited significant associations between recurrent 
urinary tract infections (Crude Hazard Ratio 2.578 
(1.208-5.498), p<0.014) and reduced urinary flow 
(Crude Hazard Ratio 0.217 (0.100-0.471), p<0.001) 
with presence of OSUI (Table 3). This was in 
agreement with previous study done by Gretchen et al. 
(27) who found that recurrent UTI causes over 
distension of the bladder due to bladder stasis which 
may damage the stretch receptors in the bladder wall. 
Bladder stasis is contributed by the kinking of urethra in 
prolapse, hence predisposed women to UTI. We also 
found a significant increase in detection of occult SUI 
with an increase in the staging of prolapse particularly 
in stages 3 (Crude Hazard Ratio 0.101 (0.031-0.328), 
p<0.001). This may be explained by the degree of 
urethral kinking and compression as well as dissipation 
of pressure away from the bladder neck. This effect is 
relatively marked in advance prolapse thus increasing 
the incidence of OSUI (17).  
 
The incidence of de novo postoperative OSUI in 
preoperatively asymptomatic continent women 
remained unclear following prolapse repair (1, 28). As 
the incidence of OSUI in this study is only a prediction 
of possible outcome following prolapse surgery, further 
larger series and longer prospective studies are needed 
to explore the true incidence and actual outcome of 
postoperative OSUI (29). Based on our data, we 
concluded that women should have a preoperative 
urodynamic screening for OSUI to identify those at risk 
of postoperative OSUI. We also found that parity, body 
mass index, history of spontaneous vertex delivery, 
history of reduced urinary flow and stage 3 utero-
vaginal prolapse were significant risk factors for OSUI 
(p<0.001). This information could be used to facilitate 
the development of a risk stratification system in the 
clinical setting in order to identify the target groups who 
are more likely to benefit from the preoperative 
urodynamics testing and have OSUI.  Hence, strategic 
plans could be implemented in terms of patient’s 
counselling, optimum surgery performed and possible 
postoperative complications anticipated. 
 
In agreement with other study, we found urodynamic 
testing after restoring prolapse anatomy with a ring 
pessary is the preferable method as it may identify 
women needing anti-incontinence procedures during 




Identifying risk factors of developing de novo OSUI as 
found in our study was essential for predicting the 
correct diagnosis. The decision whether to perform a 
combined surgery in either a one or two – step 
approaches requires weighing the possibility of 
inadequate treatment versus exposing the patient to the 
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